Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by FGPstock on Apr 21, 2022 12:14pm

Bullboard...

I always looked to stockhouse as a forum where ppl could express their opinions and insights and hopefully learn a bit more about the company, but when 1 poster tries to control the narrative and post, then re-post articles from years ago or buyout comparisons that have no relavance, then you question that poster and he unleashes a new set of meaningless posts and insults, it defeats the whole purpose of this board. It is great that some posters have tried to come up with there own analysis for the CR%, but I believe if the company made the same analysis in a public NR it would be a lot better received. TLT seems to like to operate in the dark and I believe that is why we are at $.31. One poster blamed it on the TSX exchange, but in order to get on a better exchange the stock price needs to be higher. I retired from stockhouse for a while as for years we have all been speculating on "what if's, maybe's and perhaps". For a long time they said they were going to apply for BTD after 20-25 treated. Have they applied? I am not sure if anyone knows the answer to that, but if they are truly at 60%+ CR, they should, imo...
Comment by Lesalpes29 on Apr 21, 2022 12:43pm
Since april 4th of course! Only posting here of course!
Comment by ScienceFirst on Apr 21, 2022 12:45pm
"FGPstock with an agenda" is once again doubting about TLT management!  Just like his partner "Gorf79 with an agenda"!    He's doubting that TLT will apply once they are eligible!!! Like if TLT management needed his advise!  Lolll For a long time they said they were going to apply for BTD after 20-25 treated. Have they applied? I am not ...more  
Comment by FGPstock on Apr 21, 2022 12:55pm
Management has more than proven they have made more than their share of mistakes in this trial. The history of the trial speaks for itself, imo... Pretending they have done everything right doesn't make it a reality.
Comment by Oilminerdeluxe on Apr 21, 2022 12:56pm
They have not pretended anything. Move away, please.
Comment by gojotv! on Apr 21, 2022 1:13pm
I laughed out loud at this moron's post. Management has nothing to do with this trial. They are not on the science side of things. (Plus, the trial is going well.) Wow. A transparent attempt to bash, using the basher's favourite target. Sheer nonsense.
Comment by Rumpl3StiltSkin on Apr 21, 2022 1:41pm
FGP, You've proven yourself a basher. You and GORF, lol. What a name. So you guys have a hard on for Mgmt, and Bencro it seems. I think you admitted to being sued by TLT. So what is your former Alias on this board? Maybe you won't say cuz people here will remember and realise your real agenda. I think I know who you are. Goldie!
Comment by FGPstock on Apr 21, 2022 2:23pm
@rumpy, I am far from a basher as i am pretty sure i own more shares of theralase than 99% of investors. I don't know who was sued, i think there may have been 2 lawsuits v shareholders but i can't recall and wasn't sued on either. Pretty sure bencro made that up as he feels anyone that doesn't agree w him is a basher or was/is going to b sued by the company for a simple opinion ...more  
Comment by Lesalpes29 on Apr 21, 2022 2:49pm
Are you doing this:
Comment by Lesalpes29 on Apr 21, 2022 2:49pm
Then listening to someone who posts the same dribbble over and over as an expert is even worse...
Comment by Lesalpes29 on Apr 21, 2022 2:51pm
Are you someone who posts the same dribbble over and over ... just asking!
Comment by Gorf79 on Apr 21, 2022 2:53pm
Some Facts; Science First is Bencro Bencro is notorious for continuously and viciously attacking posters with an opinion contrary to his or who express the slightest dissatisfaction with management, or management decisions, particularly financings The share price is off 35% since the morning of the recent NR The demand for shares has dramatically declined, to nearly nothing None of the above ...more  
Comment by Lesalpes29 on Apr 21, 2022 2:56pm
Laurel et Hardy... are you in the same bureau!
Comment by Gorf79 on Apr 21, 2022 3:01pm
Les please feel free to dispute any of the facts I have mentioned below. I’m most interested in hearing your rebuttal.
Comment by Lesalpes29 on Apr 21, 2022 3:09pm
I'm not here to dispute... here to read good posters that are able to talk about the science. Science look very good and it's enough for me. Laurel and Hardy are very close to my long ignore list.
Comment by Gorf79 on Apr 21, 2022 3:10pm
Please, by all means, exercise your right to ignore!
Comment by Rumpl3StiltSkin on Apr 21, 2022 4:18pm
Briacell recently sold off on good news down 30% after anouncing they recieved Fast Track
Comment by ScienceFirst on Apr 21, 2022 4:14pm
Poor little d!ckhead FGPstock!   "@gogot, how can you actually say theralase has nothing to do with the trail, they DESIGNED it!!! I agree that are not included in administering the trial, but, at the end of the day it is their design. So, yes, in my opinion, the lack of accurately calculating bladder volume falls on the trial design and tlt, not the doctors as they can't just ...more  
Comment by ScienceFirst on Apr 21, 2022 4:21pm
With this sentence, FGPstock has debunked himself. "I am far from a basher as i With his previous am pretty sure i own more shares of theralase than 99% of investors." That's the clown that wanted the head of Roger via his previous ID.  And most probably the one behind the OSC lawsuit.  
Comment by Gorf79 on Apr 21, 2022 5:03pm
Still with the lawsuit speculation Bencro. Is that your go-to tactic for suppressing opinions that differ from yours. Those who know your history are somehow exposing themselves to a company suit. I would very much enjoy that challenge. You know there was a great deal of speculation as to who you really are 3-4 years ago. Shall I post that? You shouldn’t have called me a dickhead Bencro. I can ...more  
Comment by ScienceFirst on Apr 21, 2022 6:13pm
Gorf79 ... If you don't want to be called a d!ckhead then just don't insult others and don't call them POS.
Comment by Rumpl3StiltSkin on Apr 21, 2022 6:46pm
I went over to the Briacell board and I wanted to see what was up. Curious, I didn't see Gorf or FGP over there, telling Briacell share holders that their Mgmt sucked? Or say anything abusive to anyone on that board. No, Didnt see any sign of them. Why are they just here on the TLT board??
Comment by ScienceFirst on Apr 21, 2022 7:37pm
Funny Rumpl3StiltSkin that both "Gorf79 with an agenda" and his buddy "FGPStock with an agenda" don't comment on your example of Briacell going down -30% the day after a Fast Track Approval designation.  Right there, you can see their agenda. They were both insulted that we confronted their weak arguments and opposed them with facts.  They thought that ...more  
Comment by Gorf79 on Apr 21, 2022 9:13pm
Rumpl, I have no idea who Briacell is. It looks like you would like to settle on this company as your benchmark though. If I cared enough I’d list a hundred other biotechs that actually go up on good news. You do understand that concept  right, it’s really sort of standard operating procedure for public companies... release good news competently = an increase in your share price, NOT a 35 ...more  
Comment by socksnblonds642 on Apr 21, 2022 9:23pm
These are your words no? I translate this as you saying they suck...did you mean sumpin else?  "Posters here have an incredibly low bar for management’s duty to Shareholders. even after that market cap destroying disaster of a release by management. So many are thoroughly impressed that a senior manager purchased market shares at the LOW of the day. The low of the year? Wow what ...more  
Comment by Gorf79 on Apr 21, 2022 9:29pm
I thought that message is quite clear. The release was a disaster for the share price, the evidence is provided daily between 9:30 am and 4: 00 pm if you care to check, and some lone manager buying a few shares following this at a month’s long low does not impress me.  You can can infer whatever you chose to from that statement, but I believe it to be an accurate reflection of FACT.
Comment by ScienceFirst on Apr 21, 2022 9:48pm
Gorf79 ... Don't know on which planet you live but many Russell 2000 stocks have plumetted 75-80% between Feb. 2021 and Feb. 2022.  Go check many stocks and charts.  Once again, you look like a poorly informed "investor" that is repeating himself.  
Comment by Pandora on Apr 21, 2022 10:47pm
Just for the record Briacell is a for Venture company that is in trials for breast cancer. At one point I tried to convince their CEO to take a look at TLT and TLD1433 but they chose to go with Keytruda instead. I had accumulated 30,000 shares at an average of 30 cents when in 2019 the new Chairman decided they would do a 1 for 300 consolidation (ouch). I also tried to talk him out of that but ...more  
Comment by ScienceFirst on Apr 22, 2022 7:59am
TLT is much more advanced than Briacell as we are already 40% into a Ph. 2b, with superior results than competition and an confirmation that TLD-1433 detroys cancer cells.  We just need a bit more data to make a trend more significant, see how many PR and pending convert to CR and how our DR (@450-days) trends.  The 270-days data is also important to monitor for the fully dosed patients. ...more  
Comment by ScienceFirst on Apr 22, 2022 9:06am
In my previous post, the example I forgot to add was IBRX when referring to what a Breakthrough designation can do on the market valuation. Again, IBRX, for the exact same indication than us, was valued @ 150MM$US before the FDA Breakthrough designation (Dec. 4, 2019).  (Sitting @75MM$US, we're 50% below that mark)     Then IRBX ...more  
Comment by robertshaw on Apr 22, 2022 9:13am
Thanks for the informations about Briacell history. It's great RDW insists never do Reverse Split, because it can only benifit Blowjobjoe's bosses, to all of the long shareholders like us, it's another disaster.
Comment by Rumpl3StiltSkin on Apr 22, 2022 9:43am
Gorf, Lol. What a name?!?  Selling on the news is 'a thing' I think in the cases of Briacell and TLT it can sometimes happen that some investors get spooked, other newb investors, to TLT in this case, have stops that get run. Any short traders that trade these SoN events get a bit lucky. That is all I am sayin,. You seem to want to use this as a way to indite TLT management in some ...more  
Comment by Gorf79 on Apr 22, 2022 9:55am
Rumpl, I have to admit that you have a far more dignified name.  There are many legitimate posters here but You’ve got a serious problem on your hands if Bencro is considered your most prominent poster. Trust me, volume and integrity don’t always compute.  Just watch.
Comment by Rumpl3StiltSkin on Apr 22, 2022 10:05am
 Why TLT Gorf? Why Bencro? LOL???!!! Let everyone here know your former Alias' Maybe then we can determine your agenda, no? Why TLT Gorf? Why Bencro? LOL???!!!
Comment by Gorf79 on Apr 22, 2022 10:33am
Rumpl. Some more facts Fact - No former alias Fact- Never been sued by TLT, however I’m open to it if need be Fact - the share price for a pivotal Phase 2 with very good results to date would widely be considered a pathetic disappointment Fact -  I own a substantial position but have never claimed to own more than anyone else Fact- Bencro has a less than honorable agenda Fact- Bencro ...more  
Comment by ScienceFirst on Apr 22, 2022 10:21am
I bring up with facts, perspectives, examples and sources that make Gorf79 arguments look bad.  So he tries to discredit me.  Bungee used the same tactic to discredit those opposing him, after whining on Roger with similar pattern.  Bungee was blaming Roger by saying that the share price was undervalued and should have been trading @ 1-2$.  The problem was that at that moment ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250